Recombinant monoclonal antibody specially binds to VI of human TPO. This human anti-TPO monoclonal antibody B8 can be widely used in the treatment of Graves' disease.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
MOB-999 | Recombinant Anti-TPO Antibody | ELISA, WB, FuncS | IgG |
FAMAB-0036JF | Human Anti-TPO Recombinant Antibody (clone TF3.5) | WB, ELISA, FC | Human IgG |
FAMAB-0042JF | Human Anti-TPO Recombinant Antibody (clone ICA5) | WB, ELISA, FuncS | Human IgG |
ZG-0120C | Mouse Anti-TPO Recombinant Antibody (clone ABT-TPO) | IHC-P, IF | Mouse IgG |
ZG-0121C | Mouse Anti-TPO Recombinant Antibody (clone PT0857) | WB | Mouse IgG |
There are currently no Customer reviews or questions for FAMAB-0014JF-S(P). Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.